Febuxostat
- Product NDC
- 0904-7484
- Requested package NDC
- 0904-7484-03
- 11-digit product format
- 009047484
- Labeler code
- 0904
- Product ID
- 0904-7484_2bc97ac5-e672-4bb9-b0c4-596bbe935292
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Febuxostat
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Major Pharmaceuticals
- Application
- ANDA210461
- Marketing category
- ANDA
- Marketing start
- 2024-05-22
- Marketing end
- 2026-07-31
- Substance
- FEBUXOSTAT
- Active strength
- 40 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Current FDA listing
- Yes
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0904-7484 | 0904-7484-03 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210461-001 | FEBUXOSTAT | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | |
| A210461-002 | FEBUXOSTAT | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A210461-001 | AB |
| A210461-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | BX | 2019-12-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | BX | 2019-12-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | BX | 2019-12-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | BX | 2019-12-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | BX | 2019-12-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | BX | 2019-12-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | BX | 2019-12-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | BX | 2019-12-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | BX | 2019-12-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | BX | 2019-12-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | BX | 2019-12-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | BX | 2019-12-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | BX | 2019-12-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | BX | 2019-12-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | 87673890dc5c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A210461-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A210461-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210461-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210461-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A210461-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A210461-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210461-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210461-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210461-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210461-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210461-001 | BX | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210461-002 | BX | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210461-001 | BX | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210461-002 | BX | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210461-001 | BX | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210461-002 | BX | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210461-001 | BX | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210461-002 | BX | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A210461-001 | BX | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A210461-002 | BX | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210461-001 | BX | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210461-002 | BX | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210461-001 | BX | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210461-002 | BX | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210461-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210461-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A210461-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A210461-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210461-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210461-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A210461-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A210461-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A210461-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A210461-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A210461-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A210461-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A210461-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A210461-002 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210461-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210461-002 | AB | 1 | 87673890dc5c… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Febuxostat | FEBUXOSTAT | Novadoz Pharmaceuticals LLC | d1969ea8-5178-42ee-97fc-feee8595e677 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | 210461 ANDA210461 |
| Febuxostat | FEBUXOSTAT | Major Pharmaceuticals | 164feabd-f722-445b-b81a-d975b3db5f53 | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | 210461 ANDA210461 0904-7484-03 0904-7484 00904748403 |
| Febuxostat | FEBUXOSTAT | NuCare Pharmaceuticals,Inc. | a745be75-4fa5-cbf9-e053-2995a90a3a81 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 210461 ANDA210461 |
| Febuxostat | FEBUXOSTAT | MAJOR PHARMACEUTICALS | 13a80059-46f7-4453-ab37-72744657a08a | 2024-06-04 | Boxed warning, Warnings, Adverse reactions | 210461 ANDA210461 |
| Febuxostat | FEBUXOSTAT | Aphena Pharma Solutions - Tennessee, LLC | bf4d29c8-4731-42bc-887a-d8302add9ca9 | 2020-04-22 | Boxed warning, Warnings, Adverse reactions | 210461 ANDA210461 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 253cf2a8-e060-f2e5-7334-8565436b95e4 | Product name | 6 | 20240213 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| 351abe41-466c-4dd8-840a-0fdb68318bd5 | Product name | 1 | 20230316 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0904-7484-03 | Febuxostat | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-7484-03 | EA - Each | 0904-7484 | 84b477d0-c416-471d-9794-d2a337d7b49d | 1 | 2024-07-12 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 834235 | febuxostat 40 MG Oral Tablet | PSN | 164feabd-f722-445b-b81a-d975b3db5f53 | 4 |
| 834241 | febuxostat 80 MG Oral Tablet | PSN | 164feabd-f722-445b-b81a-d975b3db5f53 | 4 |
| 834235 | febuxostat 40 MG Oral Tablet | SCD | 164feabd-f722-445b-b81a-d975b3db5f53 | 4 |
| 834241 | febuxostat 80 MG Oral Tablet | SCD | 164feabd-f722-445b-b81a-d975b3db5f53 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0904-7484-03 | 00904748403 | 30 TABLET, FILM COATED in 1 BOTTLE (0904-7484-03) | 2024-05-22 | 2026-07-31 | No | No | Historical |